IGC Pharma (IGC) Gross Profit Growth (3y) (2013 - 2025)
IGC Pharma (IGC) Gross Profit Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
411.41% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
7.16% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
IGC Pharma |
28.11 Mn |
27.85 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-9.82% |
| Jun 30, 2025 |
2.74% |
| Mar 31, 2025 |
31.32% |
| Dec 31, 2024 |
18.82% |
| Sep 30, 2024 |
73.36% |
| Jun 30, 2024 |
84.39% |
| Mar 31, 2024 |
85.02% |
| Dec 31, 2023 |
111.79% |
| Sep 30, 2023 |
88.45% |
| Jun 30, 2023 |
76.98% |
| Mar 31, 2023 |
57.91% |
| Dec 31, 2022 |
50.37% |
| Sep 30, 2022 |
68.94% |
| Jun 30, 2022 |
51.30% |
| Mar 31, 2022 |
36.06% |
| Dec 31, 2021 |
11.27% |
| Sep 30, 2021 |
28.28% |
| Jun 30, 2021 |
-14.77% |
| Mar 31, 2021 |
33.05% |
| Dec 31, 2020 |
-28.93% |
